首页 | 本学科首页   官方微博 | 高级检索  
     


Contraceptive responses of female hamsters immunized with recombinant sperm protein P26h
Authors:Dubé Evemie  Legaré Christine  Gaudreault Christian  Sullivan Robert
Affiliation:

aCentre de Recherche en Biologie de la Reproduction and Département d'Obstétrique-Gynécologie, Faculté de Médecine, Université Laval, Québec Canada

bUnité d'Ontogénie-Reproduction, Centre de Recherche, Centre Hospitalier de l'Université Laval, St-Foy, QC, Canada G1V 4G2

cCRCRH, Department of Cell Biology, University of Virginia, Charlottesville, VA 22908, USA

Abstract:BACKGROUND: A number of antigens have been characterized and proposed as potential candidates for immunocontraception. P26h, a 26-kDa hamster sperm protein located on the acrosomal cap, is known to be involved in sperm-zona pellucida interactions. Furthermore, in vivo fertilization can be blocked by active immunization of male hamsters against P26h or maltose-binding protein recombinant P26h (MBP-P26h). OBJECTIVE: The aim of this study was to investigate the immune response and reproductive function of female hamsters immunized against MBP-P26h. RESULTS: Active immunization against MBP-P26h resulted in anti-P26h circulating antibodies, with enzyme-linked immunosorbent assay (ELISA) titers showing interindividual variability. The antibodies produced by the animals immunized against MBP-P26h reacted with the native P26h protein in ELISA, in Western blot analysis and in immunostaining performed on cauda epididymal spermatozoa. Mating of immunized female hamsters resulted in a significant decrease in the number of viable fetuses only in females with high titers of anti-P26h circulating antibodies. DISCUSSION: This result is in agreement with the sperm-zona pellucida binding assay's results. Indeed, sera collected from immunized animals, and not from control animals, significantly blocked sperm-zona pellucida binding in vitro. Histological studies showed that active immunization did not cause any pathology in the reproductive tissues. CONCLUSION: These findings suggest that P26h is a potential candidate for the development of a contraceptive vaccine in both males and females.
Keywords:Sperm protein   Epididymis   Immunocontraception   Female contraception   Sperm antigen
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号